LONDON--(BUSINESS WIRE)--Technavio’s latest report on the global angina pectoris drugs market provides an analysis on the most important trends expected to impact the market outlook from 2017-2021.

That feeling of crushing pain in your chest can be a medical emergency, but it can also be angina pectoris, or "stable angina"—a symptom of coronary heart disease that can be managed with medication.

The "Angina Pectoris Drugs Market Analysis, By Therapeutic Class (Beta Blockers, Calcium Antagonists, Nitrates, Anticoagulants, ACE inhibitors, Ranolazine), By Major Markets, And Segment Forecasts, ...

Angina pectoris, often shortened to angina, is chest pain or discomfort caused by reduced blood flow to the heart and most commonly—but not always—a symptom of coronary artery disease (CAD). The term ...

DUBLIN--(BUSINESS WIRE)--The "Angina Pectoris: Global Drug Forecast and Market Analysis to 2028" report has been added to ResearchAndMarkets.com's offering. This report focuses on the following forms ...

The goals of treatment are to decrease the frequency of angina, increase longevity, and improve patients' QOL. Management of risk factors is an essential component of this therapy. Also important is ...

A drug used in the clinical treatment of angina symptoms also has an anti-inflammatory effect and reduces atherosclerotic plaques in blood vessels - thereby reducing the risk of heart attack or stroke ...

A drug used in the clinical treatment of angina symptoms also has an anti-inflammatory effect and reduces atherosclerotic plaques in blood vessels -- thereby reducing the risk of heart attack or ...